Skip to main content
. 2018 Apr 3;33(2):181–186. doi: 10.1007/s12250-018-0025-2

Table 1.

Summary of PCV2/3 detection in 340 clinical samples using the established real-time PCR.

Samples PCV2+ PCV3+ PCV2+ PCV3+
Lung 75/98 (76.5%) 66/98 (67.3%) 34/98 (34.7%)
Lymph node 93/162 (57.4%) 75/162 (46.3%) 51/162 (31.5%)
Tonsil 64/80 (80.0%) 10/80 (12.5%) 9/80 (11.3%)
Total 232/340 (68.2%) 151/340 (44.4%) 94/340 (27.6%)